These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9499110)

  • 21. Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo.
    Wadsworth SC; Zhou H; Smith AE; Kaplan JM
    J Virol; 1997 Jul; 71(7):5189-96. PubMed ID: 9188586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus vector-mediated in vivo gene transfer of OX40 ligand to tumor cells enhances antitumor immunity of tumor-bearing hosts.
    Andarini S; Kikuchi T; Nukiwa M; Pradono P; Suzuki T; Ohkouchi S; Inoue A; Maemondo M; Ishii N; Saijo Y; Sugamura K; Nukiwa T
    Cancer Res; 2004 May; 64(9):3281-7. PubMed ID: 15126371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fas ligand gene-carrying adeno-5 AdEasy viruses can be efficiently propagated in apoptosis-sensitive human embryonic retinoblast 911 cells.
    Watzlik A; Dufter C; Jung M; Opelz G; Terness P
    Gene Ther; 2000 Jan; 7(1):70-4. PubMed ID: 10680018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues.
    Yang Y; Su Q; Grewal IS; Schilz R; Flavell RA; Wilson JM
    J Virol; 1996 Sep; 70(9):6370-7. PubMed ID: 8709265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer.
    Merritt RE; Mahtabifard A; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1609-17. PubMed ID: 14666041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver.
    Liu ZX; Govindarajan S; Okamoto S; Dennert G
    J Immunol; 2001 Mar; 166(5):3035-41. PubMed ID: 11207253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.
    Zhai Y; Yang JC; Kawakami Y; Spiess P; Wadsworth SC; Cardoza LM; Couture LA; Smith AE; Rosenberg SA
    J Immunol; 1996 Jan; 156(2):700-10. PubMed ID: 8543823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts.
    Tourneur L; Malassagne B; Batteux F; Fabre M; Mistou S; Lallemand E; Lores P; Chiocchia G
    J Immunol; 2001 Aug; 167(3):1338-46. PubMed ID: 11466351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioactivities of culture supernatants from retroviral packaging cells carrying the mouse Fas ligand gene.
    Liu L; Zou P; Guo R; Xiao J; Xu Z
    J Tongji Med Univ; 2001; 21(3):215-8. PubMed ID: 12539580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression.
    Harrod KS; Hermiston TW; Trapnell BC; Wold WS; Whitsett JA
    Hum Gene Ther; 1998 Sep; 9(13):1885-98. PubMed ID: 9741427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver.
    Jooss K; Ertl HC; Wilson JM
    J Virol; 1998 Apr; 72(4):2945-54. PubMed ID: 9525615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo controlling of cellular response to pig islet xenografts by adenovirus-mediated expression of either membrane-bound human FasL or human decoy Fas.
    Kawamoto K; Tanemura M; Deguchi T; Machida T; Nishida T; Sawa Y; Doki Y; Mori M; Ito T
    Transplant Proc; 2009; 41(1):331-3. PubMed ID: 19249549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CD8 attenuates cytotoxic T cell responses against replication-defective adenovirus affording transprotection of transgenes in vivo.
    Peng Y; Falck-Pedersen E; Elkon KB
    J Immunol; 2000 Aug; 165(3):1470-8. PubMed ID: 10903752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of murine Fas ligand that affects the biological activity.
    Kayagaki N; Yamaguchi N; Nagao F; Matsuo S; Maeda H; Okumura K; Yagita H
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3914-9. PubMed ID: 9108079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination system.
    Bennett D; Sakurai F; Shimizu K; Matsui H; Tomita K; Suzuki T; Katayama K; Kawabata K; Mizuguchi H
    Mol Pharm; 2012 Dec; 9(12):3452-63. PubMed ID: 23127182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates.
    Scaria A; Sullivan JA; St George JA; Kaplan JM; Lukason MJ; Morris JE; Plog M; Nicolette C; Gregory RJ; Wadsworth SC
    Mol Ther; 2000 Nov; 2(5):505-14. PubMed ID: 11082324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble Fas ligand blocks destructive corneal inflammation in mouse models of corneal epithelial debridement and LPS induced keratitis.
    Gregory-Ksander M; Perez VL; Marshak-Rothstein A; Ksander BR
    Exp Eye Res; 2019 Feb; 179():47-54. PubMed ID: 30365944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells.
    Kikuchi T; Crystal RG
    Hum Gene Ther; 1999 May; 10(8):1375-87. PubMed ID: 10365667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
    Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
    Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.